Number of drug approval applications submitted in China 2018-2021
In 2021, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) received more than 11,600 applications for drug approvals, representing an increase of almost 14 percent from the previous year. Most of the drugs submitted for evaluation were subjected to technical reviews.